Bharat Biotech’s COVID-19 vaccine has secured regulatory approval for human trials.

Phase I and II clinical trials for Covaxin, India’s first domestic candidate for a vaccine, will begin in July. 

Read more on that story here

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.